University Of Texas/texas Am Investment Management Co sold $81k of RNTX
owner at Aileron Therapeutics, Inc.. 24,671 shares at an average of $3.27, traded Jun 10, 2024, filed Jun 12, 2024.
Score components
- +12Role10% owner
- +9Trade size$81k at market
- 0Share of holdings soldSold 1.4% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.2%, 3m -11.4%, 6m -34.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001019231-24-000025, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2024 | SOpen-market sale Common Stock | -9,577 | $3.30 | $32k | 1,768,250 | Jun 12, 2024 |
| Jun 11, 2024 | SOpen-market sale Common Stock | -5,250 | $3.25 | $17k | 1,763,000 | Jun 12, 2024 |
| Jun 11, 2024 | SOpen-market sale Common Stock | -502 | $3.35 | $1,682 | 1,762,498 | Jun 12, 2024 |
| Jun 12, 2024 | SOpen-market sale Common Stock | -9,341 | $3.25 | $30k | 1,753,157 | Jun 12, 2024 |
| Jun 12, 2024 | SOpen-market sale Common Stock | -1 | $3.28 | $3 | 1,753,156 | Jun 12, 2024 |
Related signals
Other insiders at Aileron Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | RNTXbuy Aileron Therapeutics, Inc. | Josef H Von Rickenbach director | $50k 47,060 shares | +305% | |
| 38Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor See Remarks | $25k 25,000 shares | +1222% | |
| 26Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $128k 104,183 shares | +13% | |
| 29Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $423k 306,050 shares | +44% | |
| 33Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and CEO | $898 400 shares | - | |
| 12Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $22k 6,607 shares | -0% | |
| 18Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $41k 12,315 shares | -1% | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $85k 20,315 shares | -1% | |
| 23Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $139k 31,151 shares | -2% | |
| 37Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and COO | $758 225 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.